Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03540225Phase 3Withdrawn
A Phase 3 trial of progesterone in preterm birth. Planned start Apr 2020; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03540225.